Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Naloxone for the Treatment of Opioid-Induced Pruritus: A Double-Blind, Prospective, Randomized, Controlled Study

NCT01071057 is registered in ClinicalTrials.gov with University of British Columbia as lead sponsor.

NCT NCT01071057
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01071057 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Naloxone for the Treatment of Opioid-Induced Pruritus: A Double-Blind, Prospective, Randomized, Controlled Study
Lead sponsor
University of British Columbia
Phase
Phase 2/3
Overall status
Completed
Start date
December 31, 2010
Completion date
April 30, 2013
Enrollment
92 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pruritus